| pubmed-article:20178647 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20178647 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:20178647 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:20178647 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:20178647 | lifeskim:mentions | umls-concept:C0014921 | lld:lifeskim |
| pubmed-article:20178647 | lifeskim:mentions | umls-concept:C0021747 | lld:lifeskim |
| pubmed-article:20178647 | lifeskim:mentions | umls-concept:C0022265 | lld:lifeskim |
| pubmed-article:20178647 | lifeskim:mentions | umls-concept:C0026259 | lld:lifeskim |
| pubmed-article:20178647 | lifeskim:mentions | umls-concept:C0144576 | lld:lifeskim |
| pubmed-article:20178647 | lifeskim:mentions | umls-concept:C1522484 | lld:lifeskim |
| pubmed-article:20178647 | lifeskim:mentions | umls-concept:C0376515 | lld:lifeskim |
| pubmed-article:20178647 | lifeskim:mentions | umls-concept:C0078257 | lld:lifeskim |
| pubmed-article:20178647 | lifeskim:mentions | umls-concept:C0036525 | lld:lifeskim |
| pubmed-article:20178647 | lifeskim:mentions | umls-concept:C1709059 | lld:lifeskim |
| pubmed-article:20178647 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:20178647 | pubmed:dateCreated | 2010-3-15 | lld:pubmed |
| pubmed-article:20178647 | pubmed:abstractText | To test the hypothesis that modulation of Bcl-2 with 13-cis retinoic acid (CRA)/interferon-alpha2b (IFN) with paclitaxel (TAX), or mitoxantrone, estramustine and vinorelbine (MEV) will have clinical activity in men with metastatic castrate-resistant prostate cancer (CRPC). | lld:pubmed |
| pubmed-article:20178647 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20178647 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20178647 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20178647 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20178647 | pubmed:issn | 1479-5876 | lld:pubmed |
| pubmed-article:20178647 | pubmed:author | pubmed-author:RothBruceB | lld:pubmed |
| pubmed-article:20178647 | pubmed:author | pubmed-author:WildingGeorge... | lld:pubmed |
| pubmed-article:20178647 | pubmed:author | pubmed-author:DiPaolaRobert... | lld:pubmed |
| pubmed-article:20178647 | pubmed:author | pubmed-author:WhiteEileenE | lld:pubmed |
| pubmed-article:20178647 | pubmed:author | pubmed-author:VaughnDavidD | lld:pubmed |
| pubmed-article:20178647 | pubmed:author | pubmed-author:CarducciMicha... | lld:pubmed |
| pubmed-article:20178647 | pubmed:author | pubmed-author:SteinMarkM | lld:pubmed |
| pubmed-article:20178647 | pubmed:author | pubmed-author:ChenYu-HuiYH | lld:pubmed |
| pubmed-article:20178647 | pubmed:author | pubmed-author:Patrick-Mille... | lld:pubmed |
| pubmed-article:20178647 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20178647 | pubmed:volume | 8 | lld:pubmed |
| pubmed-article:20178647 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20178647 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20178647 | pubmed:pagination | 20 | lld:pubmed |
| pubmed-article:20178647 | pubmed:dateRevised | 2010-9-30 | lld:pubmed |
| pubmed-article:20178647 | pubmed:meshHeading | pubmed-meshheading:20178647... | lld:pubmed |
| pubmed-article:20178647 | pubmed:meshHeading | pubmed-meshheading:20178647... | lld:pubmed |
| pubmed-article:20178647 | pubmed:meshHeading | pubmed-meshheading:20178647... | lld:pubmed |
| pubmed-article:20178647 | pubmed:meshHeading | pubmed-meshheading:20178647... | lld:pubmed |
| pubmed-article:20178647 | pubmed:meshHeading | pubmed-meshheading:20178647... | lld:pubmed |
| pubmed-article:20178647 | pubmed:meshHeading | pubmed-meshheading:20178647... | lld:pubmed |
| pubmed-article:20178647 | pubmed:meshHeading | pubmed-meshheading:20178647... | lld:pubmed |
| pubmed-article:20178647 | pubmed:meshHeading | pubmed-meshheading:20178647... | lld:pubmed |
| pubmed-article:20178647 | pubmed:meshHeading | pubmed-meshheading:20178647... | lld:pubmed |
| pubmed-article:20178647 | pubmed:meshHeading | pubmed-meshheading:20178647... | lld:pubmed |
| pubmed-article:20178647 | pubmed:meshHeading | pubmed-meshheading:20178647... | lld:pubmed |
| pubmed-article:20178647 | pubmed:meshHeading | pubmed-meshheading:20178647... | lld:pubmed |
| pubmed-article:20178647 | pubmed:meshHeading | pubmed-meshheading:20178647... | lld:pubmed |
| pubmed-article:20178647 | pubmed:meshHeading | pubmed-meshheading:20178647... | lld:pubmed |
| pubmed-article:20178647 | pubmed:meshHeading | pubmed-meshheading:20178647... | lld:pubmed |
| pubmed-article:20178647 | pubmed:meshHeading | pubmed-meshheading:20178647... | lld:pubmed |
| pubmed-article:20178647 | pubmed:meshHeading | pubmed-meshheading:20178647... | lld:pubmed |
| pubmed-article:20178647 | pubmed:meshHeading | pubmed-meshheading:20178647... | lld:pubmed |
| pubmed-article:20178647 | pubmed:meshHeading | pubmed-meshheading:20178647... | lld:pubmed |
| pubmed-article:20178647 | pubmed:meshHeading | pubmed-meshheading:20178647... | lld:pubmed |
| pubmed-article:20178647 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20178647 | pubmed:articleTitle | A randomized phase II trial of mitoxantrone, estramustine and vinorelbine or bcl-2 modulation with 13-cis retinoic acid, interferon and paclitaxel in patients with metastatic castrate-resistant prostate cancer: ECOG 3899. | lld:pubmed |
| pubmed-article:20178647 | pubmed:affiliation | Department of Medicine, The Cancer Institute of New Jersey, UMDNJ-RWJMS, New Brunswick NJ, USA. dipaolrs@umdnj.edu | lld:pubmed |
| pubmed-article:20178647 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20178647 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:20178647 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| entrez-gene:596 | entrezgene:pubmed | pubmed-article:20178647 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:20178647 | lld:entrezgene |
